Postmenopausal breast cancer, androgens, and aromatase inhibitors

By Campagnoli C.  

Breast Cancer Research and Treatment, Vol. 139, Iss. 1, 2013-05 ,pp. : 1-11

Springer Publishing Company

Access to resources Recommend Favorite

Aromatase inhibitors reverse tamoxifen induced endometrial ultrasonographic changes in postmenopausal breast cancer patients

By Markovitch O.   Tepper R.   Fishman A.   Aviram R.   Cohen I.  

Breast Cancer Research and Treatment, Vol. 101, Iss. 2, 2007-01 ,pp. : 185-190

Springer Publishing Company

Access to resources Recommend Favorite

Clinical Evaluation of the Use of Exemestane as Further Hormonal Therapy after Nonsteroidal Aromatase Inhibitors in Postmenopausal Metastatic Breast Cancer Patients

By Carlini Paolo   Michelotti Andrea   Ferretti Gianluigi   Ricci Sergio   Giannarelli Diana   Pellegrini Manuela   Cresti Nicola   Cosimo Serena Di   Bria Emilio   Papaldo Paola   Fabi Alessandra   Ruggeri Enzo Maria   Milella Michele   Alimonti Andrea   Salesi Nello   Cognetti Francesco  

Cancer Investigation, Vol. 25, Iss. 2, 2007-03 ,pp. : 102-105

Informa Healthcare

Access to resources Recommend Favorite

Optimizing the use of aromatase inhibitors in adjuvant therapy for postmenopausal patients with hormone-responsive early breast cancer: current and future prospects

By Jonat Walter   Hilpert Felix  

Journal of Cancer Research and Clinical Oncology, Vol. 132, Iss. 6, 2006-06 ,pp. : 343-355

Springer Publishing Company

Access to resources Recommend Favorite

Long-Term Transvaginal Ultrasonographic Endometrial Follow-up in Postmenopausal Breast Cancer Patients with Tamoxifen Treatment

By Nahari C.   Tepper R.   Beyth Y.   Flex D.   Figer A.   Cohen I.  

Gynecologic Oncology, Vol. 74, Iss. 2, 1999-08 ,pp. : 222-226

Elsevier

Access to resources Recommend Favorite